Molecular mechanisms of cardioprotection by a novel grape seed proanthocyanidin extract.

[1]  E. Hickey,et al.  Differential effects of IH636 grape seed proanthocyanidin extract and a DNA repair modulator 4-aminobenzamide on liver microsomal cytochrome 4502E1-dependent aniline hydroxylation , 2001, Molecular and Cellular Biochemistry.

[2]  S. Joshi,et al.  The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells , 1999, Molecular and Cellular Biochemistry.

[3]  C. Sen,et al.  Regulation of inducible adhesion molecule expression in human endothelial cells by grape seed proanthocyanidin extract , 2004, Molecular and Cellular Biochemistry.

[4]  P. Kovacs,et al.  Grape seed proanthocyanidins improved cardiac recovery during reperfusion after ischemia in isolated rat hearts. , 2002, The American journal of clinical nutrition.

[5]  J. Belleville.  The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. , 2002, Nutrition.

[6]  Á. Simonyi,et al.  The "French Paradox" and beyond: neuroprotective effects of polyphenols. , 2002, Free radical biology & medicine.

[7]  C. Sen,et al.  Functional genomics: high-density oligonucleotide arrays. , 2002, Methods in enzymology.

[8]  A. Farré,et al.  Heart Failure, Redox Alterations, and Endothelial Dysfunction , 2001, Hypertension.

[9]  L. Miller,et al.  EPIDEMIOLOGY OF HEARY FAILURE , 2001 .

[10]  J. Towbin.  Molecular genetic basis of sudden cardiac death. , 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[11]  Á. Tósaki,et al.  Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. , 2001, Free radical biology & medicine.

[12]  C. Sen,et al.  Upregulation of oxidant-induced VEGF expression in cultured keratinocytes by a grape seed proanthocyanidin extract. , 2001, Free radical biology & medicine.

[13]  S. Joshi,et al.  The cellular and molecular basis of health benefits of grape seed proanthocyanidin extract. , 2001, Current pharmaceutical biotechnology.

[14]  J. Vinson,et al.  Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. , 2001, Atherosclerosis.

[15]  D. Das,et al.  Transgene overexpression of αB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion , 2001 .

[16]  S. Dzhekova-Stojkova,et al.  Menopause, Coronary Artery Disease and Antioxidants , 2001, Clinical chemistry and laboratory medicine.

[17]  D. Bagchi,et al.  Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract. , 2001, Drugs under experimental and clinical research.

[18]  N. Maulik,et al.  SAPKs regulation of ischemic preconditioning. , 2000, American journal of physiology. Heart and circulatory physiology.

[19]  S. Joshi,et al.  Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. , 2000, Toxicology.

[20]  S. Hazen,et al.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.

[21]  D. Bagchi,et al.  Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: a pilot study. , 2000, Journal of medicine.

[22]  D. Bagchi,et al.  In vivo protection of dna damage associated apoptotic and necrotic cell deaths during acetaminophen-induced nephrotoxicity, amiodarone-induced lung toxicity and doxorubicin-induced cardiotoxicity by a novel IH636 grape seed proanthocyanidin extract. , 2000, Research communications in molecular pathology and pharmacology.

[23]  M. A. Kumar,et al.  A novel proanthocyanidin IH636 grape seed extract increases in vivo Bcl-XL expression and prevents acetaminophen-induced programmed and unprogrammed cell death in mouse liver. , 1999, Archives of biochemistry and biophysics.

[24]  D. Das,et al.  Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. , 1999, Journal of molecular and cellular cardiology.

[25]  D. Bagchi,et al.  Smokeless tobacco, oxidative stress, apoptosis, and antioxidants in human oral keratinocytes. , 1999, Free radical biology & medicine.

[26]  Amos Bairoch,et al.  The PROSITE database, its status in 1999 , 1999, Nucleic Acids Res..

[27]  M. Pincus,et al.  MEKK1/JNK signaling stabilizes and activates p53. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Bagchi,et al.  Protective effects of grape seed proanthocyanidins and selected antioxidants against TPA-induced hepatic and brain lipid peroxidation and DNA fragmentation, and peritoneal macrophage activation in mice. , 1998, General pharmacology.

[29]  M. Muda,et al.  Bcl-2 Undergoes Phosphorylation by c-Jun N-terminal Kinase/Stress-activated Protein Kinases in the Presence of the Constitutively Active GTP-binding Protein Rac1* , 1997, The Journal of Biological Chemistry.

[30]  David W. Dawson,et al.  CD36 Mediates the In Vitro Inhibitory Effects of Thrombospondin-1 on Endothelial Cells , 1997, The Journal of cell biology.

[31]  D. Bagchi,et al.  Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. , 1997, Research communications in molecular pathology and pharmacology.

[32]  H. K. Sluss,et al.  Selective interaction of JNK protein kinase isoforms with transcription factors. , 1996, The EMBO journal.

[33]  Jun Wu,et al.  Recombinant GST/CD36 Fusion Proteins Define a Thrombospondin Binding Domain , 1995, The Journal of Biological Chemistry.

[34]  P. Brickell,et al.  src‐related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells , 1994, FEBS letters.

[35]  John Calvin Reed,et al.  Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. , 1994, Oncogene.

[36]  L. Stanton,et al.  CD36 is a receptor for oxidized low density lipoprotein. , 1993, The Journal of biological chemistry.

[37]  K. Prasad,et al.  Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. , 1993, American heart journal.

[38]  H. Ikeda,et al.  Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine. , 1992, Blood.

[39]  S. Renaud,et al.  Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.

[40]  C. Cross,et al.  Free radicals, antioxidants, and human disease: where are we now? , 1992, The Journal of laboratory and clinical medicine.

[41]  J. Barnwell,et al.  Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Das,et al.  Polymorphonuclear leucocytes as potential source of free radicals in the ischaemic-reperfused myocardium. , 1990, European heart journal.